Difference between revisions of "WSI21-135"
From MGH Learn Pathology
(Updating subject, access, and performer) |
(Edited automatically from page learn:wsidashboard.) |
||
(15 intermediate revisions by 5 users not shown) | |||
Line 3: | Line 3: | ||
|category=409073007 | |category=409073007 | ||
|priority=routine | |priority=routine | ||
+ | |code=study | ||
|orderDetail=order | |orderDetail=order | ||
+ | |authoredOn=July 06, 2021 01:07:33 PM | ||
+ | |requester=Em99 | ||
|locationCode=learn | |locationCode=learn | ||
− | | | + | |access=public |
+ | |subject=MGH | ||
+ | |performer=MGH | ||
+ | |supportingInfo=Cytology | ||
|requisition=Cytology | |requisition=Cytology | ||
− | |||
|reasonCode=Peritoneal Washings | |reasonCode=Peritoneal Washings | ||
− | |||
− | |||
− | |||
− | |||
− | |||
}} | }} | ||
{{status | {{status | ||
|status=completed | |status=completed | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Si787 | ||
|authoredOn=March 09, 2022 12:13:55 PM | |authoredOn=March 09, 2022 12:13:55 PM | ||
− | |requester= | + | }} |
+ | {{status | ||
+ | |status=active | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Api0 | ||
+ | |authoredOn=Jul 21, 2022 15:11:58 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=submitted | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Nov 15, 2022 14:29:00 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=received | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Nov 15, 2022 15:23:46 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=scanning | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Nov 30, 2022 21:05:31 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=completed | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Nov 30, 2022 21:06:45 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=active | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Cfh13 | ||
+ | |authoredOn=Feb 10, 2023 18:57:42 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=submitted | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Feb 17, 2023 20:43:23 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=received | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 03, 2023 14:09:11 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=scanning | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 03, 2023 14:13:00 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=completed | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 03, 2023 14:19:49 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=active | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Td693 | ||
+ | |authoredOn=Mar 09, 2023 19:06:47 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=submitted | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 10, 2023 13:40:00 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=received | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 10, 2023 13:58:41 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=scanning | ||
+ | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 28, 2023 12:59:54 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=completed | ||
|identifier=WSI21-135 | |identifier=WSI21-135 | ||
+ | |requester=Aja51 | ||
+ | |authoredOn=Mar 28, 2023 13:44:46 | ||
}} | }} |
Latest revision as of 08:44, March 28, 2023
Request details
Toggle columns: Diagnosis
Case | Clinical history | Requester | Diagnosis |
---|---|---|---|
Case | Clinical history | Requester | Diagnosis |
| 71 YO male with h/o gastroesophageal cancer | Ndk6 | Metastatic adenocarcinoma with signet ring features |
| 71 YO female with a peritoneal mass | Ndk6 | Poorly differentiated adenocarcinoma |
| 76 YO female with a pelvic mass | Ndk6 | Metastatic high-grade serous carcinoma |
| Pelvic mass | Td693 | Endometriosis |
| 57 YO • uterine neoplasm | Td693 | SMARCA4-deficient undifferentiated uterine sarcoma |
| 58 yo f w/ pelvic mass | Ndk6 | Metastatic adenocarcinoma resection dx: High-grade serous carcinoma |
| 40 yo f w/ history of gastric adenocarcinoma • w/ signet ring features | Ndk6 | Metastatic adenocarcinoma |
| 54 yo f w/ stomach mass | Ndk6 | Metastatic signet ring cell adenocarcinoma consistent with gastric primary |